Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2007 Oct;64(4):406-14.
doi: 10.1111/j.1365-2125.2007.03010.x. Epub 2007 Aug 31.

The contribution of observational studies to the knowledge of drug effectiveness in heart failure

Daniela Dobre  1 , Dirk J van Veldhuisen, Mike J L DeJongste, Eric van Sonderen, Olaf H Klungel, Robbert Sanderman, Adelita V Ranchor, Flora M Haaijer-Ruskamp
Affiliations
Review

The contribution of observational studies to the knowledge of drug effectiveness in heart failure

Daniela Dobre et al. Br J Clin Pharmacol. 2007 Oct.

Abstract

Aims: Randomized controlled trials (RCTs) are the golden standard for the assessment of drug efficacy. Little is known about the add-on value of observational studies in heart failure (HF). We aimed to assess the contribution of observational studies to actual knowledge regarding the effectiveness of angiotensin-converting enzyme inhibitors (ACEI), and beta-blockers (BB) in HF.

Methods: Observational studies that assessed the effectiveness of ACEI and BB in HF were identified by searching Medline, Embase, Cochrane Database (1990-2005) and the bibliographies of published articles. Cohort, case-control and time-series analysis studies were considered for inclusion. Studies with <100 patients and those who did not perform a multivariate analysis were excluded.

Results: A total of 23 cohort studies met the inclusion criteria. Studies of ACEI and BB showed a decrease in mortality with drug use in elderly patients with a broad range of ejection fraction (EF), and in those with depressed EF. Additionally, they showed a decrease in mortality in patients with renal insufficiency. The effect of ACEI and BB in HF with preserved EF was not clear, although last evidence suggests a potential benefit. Low-dose ACEI and BB may have beneficial effects. Target doses of ACEI seemed superior to low doses, but there was no clear dose-response relationship.

Conclusions: Observational studies in HF validate the effectiveness of ACEI and BB in populations underrepresented or excluded from RCTs. Observational studies of drug effectiveness provide relevant additional information for clinical practice.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Collins R, MacMahon S. Reliable assessment of the effects of treatment on mortality and major morbidity, I. Clinical trials. Lancet. 2001;357:373–80. - PubMed
    1. Yusuf S. Randomised controlled trials in cardiovascular medicine: past achievements, future challenges. BMJ. 1999;319:564–8. - PMC - PubMed
    1. McKee M, Britton A, Black N, McPherson K, Sanderson C, Bain C. Methods in health services research. Interpreting the evidence: choosing between randomised and non-randomised studies. BMJ. 1999;319:312–5. - PMC - PubMed
    1. Lenzen MJ, Boersma E, Scholte OP, Reimer WJ, Balk AH, Komajda M, Swedberg K, Follath F, Jimenez-Navarro M, Simoons ML, Cleland JG. Under-utilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials: a report from the Euro Heart Survey on Heart Failure. Eur Heart J. 2005;26:2706–13. - PubMed
    1. McDonald K. Current guidelines in the management of chronic heart failure: practical issues in their application to the community population. Eur J Heart Fail. 2005;7:317–21. - PubMed

Publication types

MeSH terms

Substances